Related Experiment Videos
Complex gel permeation assays for screening combinatorial libraries.
M E Schurdak1, M J Voorbach, L Gao
1Department of Biological Screening, Abbott Laboratories, Abbott Park, IL 60064-3500, USA. mark.schurdak@abbott.com
Journal of Biomolecular Screening
|November 2, 2001
Summary
Gel permeation assays efficiently screen compound libraries for drug discovery. This study details three novel assays, including a neuraminidase inhibitor screen, discovering new acyclic neuraminidase inhibitors.
Area of Science:
- Biochemistry
- Drug Discovery
- Assay Development
Background:
- Gel permeation assays are standard for screening solid-supported combinatorial libraries.
- Developing complex assays is crucial for high-throughput screening (HTS) operations.
Purpose of the Study:
- To report three distinct gel permeation assays for screening compound libraries.
- To demonstrate the adaptability of gel permeation assays for complex biological targets.
- To identify novel inhibitors for influenza neuraminidase.
Main Methods:
- Utilized gel permeation chromatography for library screening.
- Developed a simple enzymatic assay for neuraminidase inhibitors.
- Created complex ligand-receptor assays for interleukin-8 (IL-8)/IL-8 receptor and urokinase/urokinase receptor interactions.
- Incorporated cell-based and ELISA-type formats into gel permeation assays.
Main Results:
- Successfully screened combinatorial libraries using gel permeation assays.
- Identified a novel series of acyclic inhibitors targeting influenza neuraminidase.
- Demonstrated the feasibility of complex assays, including cell-based and ELISA formats, within a gel permeation framework.
- Validated the utility of these assays in high-throughput screening.
Conclusions:
- Gel permeation assays can be adapted for complex biological targets beyond simple enzymatic assays.
- This methodology enables routine screening of diverse compound collections against various targets.
- The developed assays are valuable tools for drug discovery and HTS operations.